EU Commission Grants Sodium Dichromate Authorisation Applications

The European Commission has granted authorisations to five companies for a use of Sodium dichromate.
Solvay Portugal, Kemira Chemicals, Electroquimica De Hernani, Caffaro Brescia and Ercros are permitted to use the substance as:
an additive for suppressing parasitic reactions and Oxygen evolution, pH buffering and cathode corrosion protection in the electrolytic manufacture of sodium chlorate with or without subsequent production of Chlorine dioxide or sodium chlorite.
The recommended review period expires on 21 September 2029.
The Commission has also granted an application from BASF for industrial use of 1,2-dichloroethane (EDC) as a recyclable solvent and extraction agent in a closed system for purification of 1,3,5-trioxane.
The recommended review period expires on 22 November 2024.
MSC Agrees BPA is an Endocrine Disruptor
2026-08-15
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Covestro CEO: The EU Must Decide Which Industries to Protect, or Energy-Intensive Sectors Will Move Out
-
INEOS Warns Chinese Chemical “Dumping” Is Hitting Europe’s Industry
-
India Imposes Final Anti‑Dumping Duties on Ethylenediamine from China, EU, Saudi Arabia, and Taiwan, China, with Top Rate of $575/tonne
-
EU Finalizes Anti-Dumping Duties on BDO from China, with Rates up to 113.7%
-
EU mulls expanding tariff scope on Chinese chemicals, sector-wide measures in the pipeline
-
EU Clears Carlyle's Acquisition of BASF's Coatings Business, but Demands Divestment of Nouryon's Polysulfide Assets: What Are the Underlying Risks?
-
Applications and Safety of Sodium Dichromate
-
EU: Metribuzin is about to be withdrawn from the EU market
-
The EU review removed the restriction on the use of Metconazole as a fungicide and plant growth regulator in the previous approval
-
Chemical production in the 27 EU countries has continued to recover, and the market recovery is still cautious
Recommend Reading
-
Canada Issues Non-Compliance Notice to Dr. Reddy’s on Semaglutide Generic
-
FDA Names Veteran Oncology Regulator Pazdur as Director of Drug Review Center
-
FDA Orders Removal of “Suicidality Warning”: Are Weight-Loss Blockbusters Finally Cleared—or Is Regulators Giving the Market a Reality Check?
-
China’s Hybio Takes Generic Tirzepatide to FDA: Lilly’s GLP-1 Fortress Gets a Warning Shot
-
Medicare’s $50 GLP-1 Door Opens: Weight-Loss Drug Demand Just Got Bigger
-
Lithium Carbonate Prices Under Pressure and Falling
-
Insufficient Cost and Demand Support; PTA Prices to Weaken
-
Costs Drop Significantly, Prices of 2-Ethylhexanol Fall in China
-
Supply remains generally loose, the acrylonitrile market fluctuates within a range
-
Raw Material Prices Rise While Finished Product Prices Fall! Melamine Caught in a Bull-Bear Tug-of-War, When Will the Bottom Turning Point Appear